136 related articles for article (PubMed ID: 34882169)
1. Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial.
Porter AB; Liu H; Kohli S; Cerhan JL; Sloan J; McMurray RP; Le-Rademacher J; Loprinzi CL; Villano JL; Kizilbash SH; Mehta MP; Jaeckle KA; Brown PD
JAMA Oncol; 2022 Feb; 8(2):259-267. PubMed ID: 34882169
[TBL] [Abstract][Full Text] [Related]
2. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.
Page BR; Shaw EG; Lu L; Bryant D; Grisell D; Lesser GJ; Monitto DC; Naughton MJ; Rapp SR; Savona SR; Shah S; Case D; Chan MD
Neuro Oncol; 2015 Oct; 17(10):1393-401. PubMed ID: 25972454
[TBL] [Abstract][Full Text] [Related]
3. A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.
Berenson JR; Yellin O; Shamasunder HK; Chen CS; Charu V; Woliver TB; Sanani S; Schlutz M; Nassir Y; Swift RA; Andreu-Vieyra C; Vescio R
Support Care Cancer; 2015 Jun; 23(6):1503-12. PubMed ID: 25370889
[TBL] [Abstract][Full Text] [Related]
4. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.
Lee EQ; Muzikansky A; Drappatz J; Kesari S; Wong ET; Fadul CE; Reardon DA; Norden AD; Nayak L; Rinne ML; Alexander BM; Arvold ND; Doherty L; Stefanik J; LaFrankie D; Ruland SF; Pulverenti J; Smith KH; Gaffey SC; Hammond S; Wen PY
Neuro Oncol; 2016 Jun; 18(6):849-54. PubMed ID: 26902850
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
[TBL] [Abstract][Full Text] [Related]
7. Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial.
Rabkin JG; McElhiney MC; Rabkin R
Psychosomatics; 2011; 52(4):328-36. PubMed ID: 21777715
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
10. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.
Calabrese JR; Frye MA; Yang R; Ketter TA;
J Clin Psychiatry; 2014 Oct; 75(10):1054-61. PubMed ID: 25099397
[TBL] [Abstract][Full Text] [Related]
14. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
Lower EE; Malhotra A; Surdulescu V; Baughman RP
J Pain Symptom Manage; 2013 Feb; 45(2):159-69. PubMed ID: 22917711
[TBL] [Abstract][Full Text] [Related]
15. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
Menn SJ; Yang R; Lankford A
J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
[TBL] [Abstract][Full Text] [Related]
16. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
[TBL] [Abstract][Full Text] [Related]
17. Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial.
Heckler CE; Garland SN; Peoples AR; Perlis ML; Shayne M; Morrow GR; Kamen C; Hoefler J; Roscoe JA
Support Care Cancer; 2016 May; 24(5):2059-2066. PubMed ID: 26542272
[TBL] [Abstract][Full Text] [Related]
18. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder.
Rosenberg RP; Bogan RK; Tiller JM; Yang R; Youakim JM; Earl CQ; Roth T
Mayo Clin Proc; 2010 Jul; 85(7):630-8. PubMed ID: 20530317
[TBL] [Abstract][Full Text] [Related]
19. Armodafinil for fatigue associated with menopause: an open-label trial.
Meyer F; Freeman MP; Petrillo L; Barsky M; Galvan T; Kim S; Cohen L; Joffe H
Menopause; 2016 Feb; 23(2):209-14. PubMed ID: 26125538
[TBL] [Abstract][Full Text] [Related]
20. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial.
Boele FW; Douw L; de Groot M; van Thuijl HF; Cleijne W; Heimans JJ; Taphoorn MJ; Reijneveld JC; Klein M
Neuro Oncol; 2013 Oct; 15(10):1420-8. PubMed ID: 23925452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
